Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

The full indication for vilobelimab is as a treatment for adult patients with SARS‑CoV-2‑induced ARDS who are receiving ...

The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

Nattawat Klomjit, MD, shares insights on managing IgA nephropathy and C3 glomerulopathy, including innovative drugs that target kidney inflammation and proteinuria.

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

Increased exposure to fine particulate matter during pregnancy significantly increased the likelihood of having a spontaneous ...

Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...

The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.

For decades, no-show patients have proven to be a costly problem for physicians. In fact, missed appointments lead to a ...

Evidence-based smoking cessation treatment within 6 months of a cancer diagnosis yielded the largest survival benefit, ...

Parents often worry that their child is a poor eater, so health professionals need to know what's normal and when ...

Socioeconomic and educational disparities significantly affect the access of women to cancer screening and care in Europe.